Daniel Coley

Investor · Cofounders Capital

Leads rounds

Email

Verified, deliverable email

Investing in B2B software in the Southeast US

Stages: Series A, Seed
Sectors: Health tech, SaaS
Cheque size: €230k–€1.8M
Freshness: Verified today

Notable investments

TEDUSeed · $2M · 2024
EcomapSeed-2 · $3.5 · 2023
Mercy BioAnalyticsSeries A · $41M · 2023
Alpheus MedicalSeries A · $14M · 2022
NaverisSeries A · $33M · 2022
Auron TherapeuticsSeries A · $48M · 2022
LunitPre-IPO Round · $26M · 2021
Immunitas TherapeuticsSeries B · $58M · 2021

Frequently co-invests with

Alexandra CantleyPolaris PartnersBrian HalakMedical Excellence Capital, LLCChristoph WestphalLongwood FundConrad WangOrbiMedEric Shiozaki (DCVC (Data Collective))Garheng KongHealthQuest CapitalGeeta VemuriAgent CapitalImran EbaAction Potential Venture CapitalIsaac CiechanoverKlaus VeitingerOrbiMedLaura BrassMPM BioImpactLucio IannoneLeaps by Bayer

Background

AssociateBrightEdge (American Cancer Society Impact Fund)2019–2023
AnalystSunTrust Robinson Humphrey2018–2019

In the press

Meet the newest associate at Durham-based VC firm Cofounders Capital | WRAL TechWire

Related lists

Health tech investors SaaS investors

Similar investors

Quan ZhouManaging Partner, IDG Capital

Raffi KamberGeneral Partner, Singular

Blake PateAnalyst, Bios Partners

Przemek OblojManaging Partner, Blue Horizon

Prashant NarangPartner, Fluid Ventures

Prachi SinhaInvestor, Axilor Ventures

Every contact is a verified, deliverable email. How Mintround verifies contacts.

Are you Daniel Coley? Request removal of this listing.